MAIA Biotechnology (MAIA) News Today $1.50 -0.03 (-1.64%) As of 10:47 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock MAIA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period MAIA Biotechnology announces publication of interim clinical data on THIO-101August 28 at 11:48 AM | msn.comMAIA Biotechnology, Inc. Announces Publication of Phase 2 THIO-101 Clinical Trial Findings in Scientific Journal CellsAugust 27 at 9:50 AM | quiverquant.comQMAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal CellsAugust 27 at 9:01 AM | globenewswire.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Up 3.3% - Here's What HappenedAugust 25, 2025 | marketbeat.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Sees Large Increase in Short InterestAugust 21, 2025 | marketbeat.comDiamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)August 18, 2025 | globenewswire.comMAIA Biotechnology granted European patent for telomere-targeting agentsAugust 13, 2025 | msn.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Down 2.4% - What's Next?July 31, 2025 | marketbeat.comMaia Biotechnology shares jump after FDA awards Fast Track statusJuly 28, 2025 | msn.comMaia Biotechnology stock soars after FDA grants Fast Track designationJuly 28, 2025 | au.investing.comMAIA Biotechnology Shares Rise After FDA Fast Track Designation for AteganosineJuly 28, 2025 | marketwatch.comMAIA Biotechnology Receives FDA’s Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung CancerJuly 28, 2025 | finance.yahoo.comMAIA Biotechnology Receives FDA's Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung CancerJuly 28, 2025 | businesswire.comMaia Biotechnology stock soars after publishing promising preclinical dataJuly 17, 2025 | investing.comMAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for Anticancer TherapyJuly 17, 2025 | businesswire.comMAIA Biotechnology Announces First Patient Dosed in ... - MorningstarJuly 11, 2025 | morningstar.comMMAIA Biotechnology doses first patient in expansion of Phase II lung cancer trialJuly 10, 2025 | finance.yahoo.comMAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung CancerJuly 9, 2025 | finance.yahoo.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Up 0.5% - Still a Buy?July 9, 2025 | marketbeat.comMAIA Biotechnology to Present Two Posters Featuring Cancer Telomere-Targeting Agents at FEBS 2025 CongressJuly 1, 2025 | finance.yahoo.comMAIA Biotechnology appoints HCC experts to scientific advisory boardJune 26, 2025 | uk.investing.comMAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory BoardJune 24, 2025 | finance.yahoo.comMAIA Biotechnology partners with Roche for cancer treatment studiesJune 20, 2025 | uk.investing.comMAIA Biotechnology, Roche sign supply agreement for cancer therapiesJune 19, 2025 | finance.yahoo.comMAIA’s New Agreement With Big Pharma Roche Turns Retail Investors Bullish As Stock SoarsJune 18, 2025 | msn.comMAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer TherapiesJune 18, 2025 | businesswire.comMAIA Biotechnology to Present at BIO International Convention 2025June 10, 2025 | businesswire.comStan Smith Acquires 33,333 Shares of MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) StockJune 6, 2025 | insidertrades.comMaia Biotechnology stock rises following positive trial resultsJune 5, 2025 | in.investing.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Stan Smith Purchases 33,333 SharesJune 5, 2025 | marketbeat.comMAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical TrialJune 5, 2025 | businesswire.comMAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung CancerJune 5, 2025 | businesswire.comMAIA Biotechnology Showcases Promising THIO-101 Trial DataJune 2, 2025 | tipranks.comMAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer TrialMay 29, 2025 | finance.yahoo.comMAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer TrialMay 27, 2025 | insidermonkey.comCORRECTING and REPLACING MAIA Biotechnology Announces Private Placement of Approximately $695,000May 27, 2025 | businesswire.comMAIA Biotechnology Increases Authorized Common Stock SharesMay 23, 2025 | tipranks.comMAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual MeetingMay 15, 2025 | businesswire.comMAIA Biotechnology Announces Director Participation in Recent Private PlacementMay 14, 2025 | businesswire.comMAIA Biotechnology (MAIA) Projected to Post Quarterly Earnings on TuesdayMay 8, 2025 | marketbeat.comCORRECTION: MAIA Biotechnology Announces $1.08 Million Private PlacementMay 5, 2025 | businesswire.comMAIA Biotechnology Announces $1.08 Million Private PlacementMay 5, 2025 | businesswire.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Short Interest UpdateMay 5, 2025 | marketbeat.comMAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to ShareholdersApril 1, 2025 | businesswire.comIs MAIA Biotechnology, Inc. (MAIA)he Cheapest Stock Insiders Are Buying In March?March 28, 2025 | insidermonkey.comMAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025March 25, 2025 | businesswire.comMAIA Biotechnology Gets USAN Approval For "Ateganosine" As Name For Telomere-Targeting DrugMarch 21, 2025 | nasdaq.comMAIA Biotechnology publishes preclinical data for telomere-targeting THIO dimerMarch 21, 2025 | msn.comMAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO ProdrugMarch 20, 2025 | businesswire.comMAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIOMarch 19, 2025 | uk.finance.yahoo.com Get MAIA Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for MAIA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MAIA Media Mentions By Week MAIA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MAIA News Sentiment▼0.061.03▲Average Medical News Sentiment MAIA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MAIA Articles This Week▼41▲MAIA Articles Average Week Get the Latest News and Ratings for MAIA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for MAIA Biotechnology and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MNPR News ACRS News TIL News SLS News KRRO News IPHA News VYGR News RAPT News CRBU News ENTA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:MAIA) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MAIA Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MAIA Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access